We are live on ! Find out more
SF

Scott Ferguson Sachem Head Capital Management

AUM $4.82B
1-Year Est. Return 73.38%
 

Scott Ferguson is the founder of Sachem Head Capital Management, an activist and fundamental equity firm. He previously worked at firms including Corvex and built a reputation for research-driven campaigns at public companies. Ferguson’s filings and activist situations are followed closely in event-driven and engagement-oriented investing circles.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+73.38%
3 Year Est. Return
+171.97%
5 Year Est. Return
+150.29%
10 Year Est. Return
+1,107.59%
AUM
$1.49B
AUM Growth
-$20.4M
Cap. Flow
-$112M
Cap. Flow %
-7.52%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
PTC icon
PTC
PTC
+$88M
2
AGN
Allergan plc
AGN
+$52.2M
3
APD icon
Air Products & Chemicals
APD
+$26.5M

Top Sells

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$125M
2
VTRS icon
Viatris
VTRS
+$115M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$37.9M

Sector Composition

Rank Sector Weight
1 Industrials 45.83%
2 Healthcare 34.09%
3 Materials 9.64%
4 Technology 6.13%
5 Communication Services 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDK
1
DELISTED
CDK Global, Inc.
CDK
$683M 45.83%
12,647,333
– –
AGN
2
DELISTED
Allergan plc
AGN
$296M 19.86%
975,000
+175,000
+22% +$52.2M
ZTS icon
3
Zoetis
ZTS
$32.1B
$212M 14.23%
4,395,000
– –
APD icon
4
Air Products & Chemicals
APD
$67.9B
$144M 9.64%
1,135,050
+194,580
+21% +$26.5M
PTC icon
5
PTC
PTC
$16.8B
$91.3M 6.13%
+2,225,000
New +$88M
TFCFA
6
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$64.2M 4.31%
1,971,762
– –
BIO icon
7
Bio-Rad Laboratories Class A
BIO
$10.2B
– –
-280,000
Closed -$37.9M
VTRS icon
8
Viatris
VTRS
$18.7B
– –
-1,945,000
Closed -$115M
SLXP
9
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-725,000
Closed -$125M

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.83B AUM 9.09% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
TI
Truepoint Inc Cincinnati, Ohio $4.79B AUM 16.42% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Scott Ferguson's Q2 2015 Portfolio in Review

As of Q2 2015, Scott Ferguson held 9 positions worth $1.49B, down 1.3% from $1.51B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Scott Ferguson withdrew a net $112M in Q2 2015, closing 3 positions. Its most notable exit was SALIX PHARMACEUTICALS LTD DEL, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 46% of assets, up from 39% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Scott Ferguson opened a new position in PTC worth $91.3M.

  • Scott Ferguson's largest Q2 2015 buy was PTC: 2,225,000 shares worth $91.3M.
  • Scott Ferguson added most to Allergan plc in Q2 2015, an estimated $52.2M increase.
  • Scott Ferguson fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $125M.
  • Scott Ferguson's ten largest holdings make up 100% of its $1.49B portfolio in Q2 2015.
  • Scott Ferguson opened 1 new position and closed 3 in Q2 2015.
  • Scott Ferguson's portfolio value fell 1.3% quarter-over-quarter to $1.49B.

Based on Sachem Head Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.